We’ve entered an era of new, sensitive and efficient low-cost biomarkers for early diagnosis of AD. These include three different kinds of blood tests. Ask your doctor about:
a new biochip test that allows for multiple tests to be run on one blood sample, with results in 3 hours;
a different blood test that diagnosed Mild Cognitive Impairment with 100% accuracy in 236 Subjects;
and a technology that detects in human blood platelets the forms of tau protein that discriminate AD and other neurodegenerative diseases from normal control groups.
As more individuals learn about these and other biomarkers for the early diagnosis of AD, more will want to have tests and engage in proactive steps for prevention.